A new study links GLP-1 drugs, used for diabetes and weight loss, to a higher risk of erectile dysfunction.

You could also catch up on your reading or reach out to someone special. Well, whatever you do, have a grand time. But be ...

NEW DELHI – The Indian government announced on March 24 that it has intensified regulatory surveillance to combat the unauthorized sale and promotion of generic GLP-1 weight loss drugs. This move ...

Indian clinics market pre-wedding weight-loss packages with Mounjaro and Wegovy India obesity drugs market seen reaching $860.34 million by 2030 Drug regulator raises concerns over potential misuse as ...

A California-based company has voluntarily recalled some of its products after they were found to contain “undeclared” pharmaceutical ingredients sildenafil and tadalafil, the FDA said FDA Adult ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." After that night, Mark started doing some online research. He had come across Viagra, which was released ...

A nationwide recall has been issued for two chocolate products after they were found to contain undeclared prescription drug ingredients, federal health officials warn. California-based Gear Isle is ...

A chocolate product sold nationwide is being recalled after federal health officials discovered it contains a hidden prescription drug. According to the U.S. Food and Drug Administration, a recall of ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Ozempic and Wegovy are injectable prescription weight-loss medicines made by Danish ...

Monday - Friday, 11:00 - 12:00 SIN/HK | 0500 - 06:00 CET In this video The patent on semaglutide, found in Novo Nordisk's Ozempic and Wegovy weight-loss drugs, expired in India on March 20. Vikrant ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions. By Rebecca ...

Swati Pradhan sees about 12 obesity patients a day at her small clinic in southern Mumbai. She expects this number to at least double from this month as Indian drug makers prepare to launch off-patent ...